INGN Inogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INGN

Price (delayed)

$6.55

Market cap

$177.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.92

Enterprise value

$99.87M

?
Relative Growth: Rel. Growth: 29
Relative Strength: Rel. Strength: 33
Relative Valuation: Rel. Valuation: 36
Relative Profitability: Rel. Profitability: 30

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental ...

Highlights
The debt has declined by 12% year-on-year and by 3.1% since the previous quarter
The revenue has increased by 3.4% year-on-year
Inogen's EPS has increased by 20% YoY but it has decreased by 7% from the previous quarter
Inogen's net income has decreased by 9% from the previous quarter but it has increased by 9% YoY
The equity has declined by 8% year-on-year and by 4.9% since the previous quarter
The gross margin has contracted by 3.9% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inogen.net
Peers: ELMD GTLS RMD

Key stats

What are the main financial stats of INGN

INGN stock price

How has the Inogen stock price performed over time
Intraday
1.87%
1 week
2.18%
1 month
2.34%
1 year
-1.8%
YTD
-2.53%
QTD
5.99%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$351.5M
Gross profit
$155.76M
Operating income
-$31.89M
Net income
-$24.9M
Gross margin
44.3%
Net margin
-7.1%
The net margin has grown by 12% year-on-year but it has declined by 9% since the previous quarter
The operating margin has grown by 9% YoY but it has contracted by 4.6% from the previous quarter
Inogen's net income has decreased by 9% from the previous quarter but it has increased by 9% YoY
INGN's operating income is up by 6% year-on-year but it is down by 6% since the previous quarter

Price vs fundamentals

How does INGN's price correlate with its fundamentals

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
0.98
P/S
0.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.28
Inogen's EPS has increased by 20% YoY but it has decreased by 7% from the previous quarter
INGN's P/B is 31% below its 5-year quarterly average of 1.4 and 4% below its last 4 quarters average of 1.0
The equity has declined by 8% year-on-year and by 4.9% since the previous quarter
The stock's price to sales (P/S) is 58% less than its 5-year quarterly average of 1.2
The revenue has increased by 3.4% year-on-year

Efficiency

How efficient is Inogen business performance
INGN's ROIC is up by 18% YoY but it is down by 7% from the previous quarter
Inogen's return on equity has increased by 13% YoY but it has decreased by 11% QoQ
Inogen's ROA has decreased by 12% from the previous quarter but it has increased by 8% YoY
Inogen's ROS has increased by 11% YoY but it has decreased by 9% from the previous quarter

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
INGN's total assets is 178% greater than its total liabilities
INGN's total assets is down by 7% year-on-year and by 4.3% since the previous quarter
The total liabilities has contracted by 7% YoY and by 3.2% from the previous quarter
The debt is 91% smaller than the equity
The debt has declined by 12% year-on-year and by 3.1% since the previous quarter
The debt to equity has decreased by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.